| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH4 MYH8 MYH13 MYO5B MYO7B SPTA1 SPTAN1 ARPC1A MYO18A NEB GSN MYO5C AVIL PPP1R9B | 1.05e-09 | 227 | 170 | 15 | GO:0051015 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.89e-08 | 38 | 170 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 4.11e-08 | 60 | 170 | 8 | GO:0005544 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.78e-08 | 118 | 170 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYH8 MYOT MYH13 MYO5B MYO7B SPTA1 SPTAN1 ARPC1A MYO18A NEB GSN MYO5C P4HB AVIL PPP1R9B PALLD | 1.52e-07 | 479 | 170 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CCSAP MYH1 MYH4 MYH8 MYOT MYH13 MYO5B MYO7B SPTA1 SPTAN1 CAPN1 ARPC1A MYO18A CCDC187 FTCD NEB DYSF GSN MYO5C LLGL2 PTPRC P4HB AVIL PPP1R9B FYN PALLD | 2.13e-06 | 1099 | 170 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | calcium ion binding | CALR3 ANXA3 ANXA4 FAT3 SPTA1 ANXA6 SPTAN1 CAPN1 ANXA13 RCVRN PCDHA11 PCDHA10 DYSF ITIH4 GSN JAG2 TLL1 PAM FER1L5 DOC2B | 6.23e-06 | 749 | 170 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | glucosidase activity | 6.43e-06 | 15 | 170 | 4 | GO:0015926 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 7.21e-05 | 2 | 170 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 1.92e-04 | 98 | 170 | 6 | GO:0048306 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 6.24e-04 | 122 | 170 | 6 | GO:0072341 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 7.09e-04 | 5 | 170 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | calmodulin binding | 8.13e-04 | 230 | 170 | 8 | GO:0005516 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH4 MYH8 MYO5B MYO7B SPTA1 SPTAN1 CAPN1 ARPC1A PRR5 MYO18A NEB DNAI3 GSN MYO5C LLGL2 GRID2IP AVIL PDCL3 PAM PPP1R9B FGR PALLD RAC1 RAC2 RAC3 FOXJ1 | 2.50e-08 | 912 | 168 | 26 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO5B MYO7B SPTA1 SPTAN1 CAPN1 ARPC1A PRR5 MYO18A NEB DNAI3 GSN MYO5C LLGL2 GRID2IP AVIL PDCL3 PAM PPP1R9B FGR PALLD RAC1 RAC2 RAC3 FOXJ1 | 3.80e-08 | 803 | 168 | 24 | GO:0030036 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL5A1 CCSAP MYO5B MYO7B IFT172 SPTA1 SPTAN1 CAPN1 ARPC1A NEB DYSF DNAI3 GSN MYO5C TUBB1 TLL1 AVIL PPP1R9B WDR73 RAC1 RAC2 RAC3 | 1.10e-05 | 957 | 168 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | phagocytosis | 1.59e-05 | 274 | 168 | 11 | GO:0006909 | |
| GeneOntologyBiologicalProcess | actin filament organization | MYO5B MYO7B SPTA1 SPTAN1 CAPN1 ARPC1A NEB DNAI3 GSN MYO5C AVIL PPP1R9B RAC1 RAC2 RAC3 | 1.89e-05 | 509 | 168 | 15 | GO:0007015 |
| GeneOntologyBiologicalProcess | protein processing | PLA2G7 PCSK2 PMPCB IFT172 CAPN1 SEC11C GSN P4HB TLL1 ACP4 ADAM17 | 2.29e-05 | 285 | 168 | 11 | GO:0016485 |
| GeneOntologyBiologicalProcess | protein maturation | PLA2G7 PCSK2 CALR3 PMPCB IFT172 CAPN1 SEC11C UNC45A PPID F13A1 GSN P4HB TLL1 PDCL3 ACP4 ADAM17 | 4.84e-05 | 619 | 168 | 16 | GO:0051604 |
| GeneOntologyBiologicalProcess | monocyte activation involved in immune response | 6.60e-05 | 2 | 168 | 2 | GO:0002280 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYH8 MYOT MYH13 MYO5B MYO7B SPTA1 SPTAN1 ARPC1A MYO18A DAPK1 NEB GSN MYO5C LLGL2 AVIL PRKCB PPP1R9B ADAM17 FGR FYN PALLD RAC1 RAC2 RAC3 | 1.28e-12 | 576 | 170 | 26 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 2.53e-08 | 59 | 170 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 1.56e-06 | 25 | 170 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.83e-06 | 28 | 170 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | secretory vesicle | DOC2A PCSK2 MGAM PTGES2 ABCC4 ANXA3 ANXA4 SPTAN1 CAPN1 PSMD2 DYSF CTSA F13A1 ITIH4 GSN MYO5C LY6G6F PTPRC CLCN5 FCN1 CLK3 CPNE3 PAM FGR FER1L5 RAC1 DOC2B | 2.94e-06 | 1246 | 170 | 27 | GO:0099503 |
| GeneOntologyCellularComponent | muscle myosin complex | 7.12e-06 | 16 | 170 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | secretory granule | PCSK2 MGAM PTGES2 ABCC4 ANXA3 ANXA4 SPTAN1 CAPN1 PSMD2 CTSA F13A1 ITIH4 GSN MYO5C LY6G6F PTPRC FCN1 CLK3 CPNE3 PAM FGR RAC1 | 2.64e-05 | 1014 | 170 | 22 | GO:0030141 |
| GeneOntologyCellularComponent | spectrin | 4.28e-05 | 9 | 170 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 ITGA11 ANXA6 SPTAN1 CAPN1 MXRA8 PCDHA10 LAP3 CLDN23 GSN LLGL2 PTPRC P4HB AVIL CPNE3 PPP1R9B TNKS1BP1 ADAM17 PALLD RAC1 RAC2 | 4.60e-05 | 976 | 170 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | focal adhesion | ITGA11 ANXA6 CAPN1 LAP3 GSN PTPRC P4HB AVIL CPNE3 ADAM17 PALLD RAC1 RAC2 | 5.40e-05 | 431 | 170 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | ITGA11 ANXA6 CAPN1 LAP3 GSN PTPRC P4HB AVIL CPNE3 ADAM17 PALLD RAC1 RAC2 | 7.13e-05 | 443 | 170 | 13 | GO:0030055 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.12e-04 | 93 | 170 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | lamellipodium | 1.15e-04 | 230 | 170 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 CCSAP MYH1 MYH4 MYH8 MYOT MYH13 SPTAN1 MYO18A NEB DYSF GSN TUBB1 AVIL TUBA4B FYN DNAH6 PALLD RAC1 RAC2 RAC3 DNAH11 | 2.36e-04 | 1179 | 170 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL5A1 CCSAP MYH1 MYH4 MYH8 MYOT MYH13 SPTAN1 MYO18A NEB DYSF GSN TUBB1 AVIL TUBA4B FYN DNAH6 PALLD RAC1 RAC2 RAC3 DNAH11 | 2.60e-04 | 1187 | 170 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | secretory granule lumen | 3.40e-04 | 325 | 170 | 10 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 3.84e-04 | 330 | 170 | 10 | GO:0060205 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 3.94e-04 | 18 | 170 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | vesicle lumen | 4.03e-04 | 332 | 170 | 10 | GO:0031983 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 6.60e-04 | 129 | 170 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | actin filament | 1.26e-03 | 146 | 170 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | endopeptidase complex | 1.48e-03 | 102 | 170 | 5 | GO:1905369 | |
| GeneOntologyCellularComponent | myofibril | 1.81e-03 | 273 | 170 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.64e-03 | 290 | 170 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | cell leading edge | 2.68e-03 | 500 | 170 | 11 | GO:0031252 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.83e-03 | 10 | 170 | 2 | GO:0036156 | |
| Domain | Myosin_head_motor_dom | 1.48e-09 | 38 | 169 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.48e-09 | 38 | 169 | 8 | PS51456 | |
| Domain | Myosin_head | 1.48e-09 | 38 | 169 | 8 | PF00063 | |
| Domain | MYSc | 1.48e-09 | 38 | 169 | 8 | SM00242 | |
| Domain | Myosin-like_IQ_dom | 1.24e-08 | 19 | 169 | 6 | IPR027401 | |
| Domain | - | 1.24e-08 | 19 | 169 | 6 | 4.10.270.10 | |
| Domain | Myosin_N | 1.60e-07 | 15 | 169 | 5 | PF02736 | |
| Domain | Myosin_N | 1.60e-07 | 15 | 169 | 5 | IPR004009 | |
| Domain | IQ | 2.49e-07 | 71 | 169 | 8 | PF00612 | |
| Domain | Myosin_tail_1 | 4.45e-07 | 18 | 169 | 5 | PF01576 | |
| Domain | Myosin_tail | 4.45e-07 | 18 | 169 | 5 | IPR002928 | |
| Domain | IQ | 6.98e-07 | 81 | 169 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.57e-06 | 90 | 169 | 8 | IPR000048 | |
| Domain | IQ | 2.02e-06 | 93 | 169 | 8 | PS50096 | |
| Domain | ANX | 4.34e-06 | 13 | 169 | 4 | SM00335 | |
| Domain | Annexin_repeat_CS | 4.34e-06 | 13 | 169 | 4 | IPR018252 | |
| Domain | Annexin | 4.34e-06 | 13 | 169 | 4 | PF00191 | |
| Domain | Annexin_repeat | 4.34e-06 | 13 | 169 | 4 | IPR018502 | |
| Domain | ANNEXIN | 4.34e-06 | 13 | 169 | 4 | PS00223 | |
| Domain | - | 4.34e-06 | 13 | 169 | 4 | 1.10.220.10 | |
| Domain | Annexin | 6.03e-06 | 14 | 169 | 4 | IPR001464 | |
| Domain | Doc2 | 8.14e-05 | 2 | 169 | 2 | IPR014638 | |
| Domain | FerA | 2.43e-04 | 3 | 169 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 2.43e-04 | 3 | 169 | 2 | IPR012560 | |
| Domain | FerA | 2.43e-04 | 3 | 169 | 2 | PF08165 | |
| Domain | Gal_mutarotase_N | 4.83e-04 | 4 | 169 | 2 | IPR031727 | |
| Domain | DysFC | 4.83e-04 | 4 | 169 | 2 | SM00694 | |
| Domain | DysFN | 4.83e-04 | 4 | 169 | 2 | SM00693 | |
| Domain | NtCtMGAM_N | 4.83e-04 | 4 | 169 | 2 | PF16863 | |
| Domain | Peroxin/Ferlin | 4.83e-04 | 4 | 169 | 2 | IPR006614 | |
| Domain | - | 5.23e-04 | 73 | 169 | 5 | 2.60.120.260 | |
| Domain | RCC1 | 7.41e-04 | 20 | 169 | 3 | PF00415 | |
| Domain | RHO | 7.41e-04 | 20 | 169 | 3 | PS51420 | |
| Domain | FerI | 8.00e-04 | 5 | 169 | 2 | SM01202 | |
| Domain | FerB | 8.00e-04 | 5 | 169 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 8.00e-04 | 5 | 169 | 2 | IPR012561 | |
| Domain | Ferlin_C | 8.00e-04 | 5 | 169 | 2 | PF16165 | |
| Domain | GLYCOSYL_HYDROL_F1_1 | 8.00e-04 | 5 | 169 | 2 | PS00572 | |
| Domain | Ferlin_C | 8.00e-04 | 5 | 169 | 2 | IPR032362 | |
| Domain | Glyco_hydro_1 | 8.00e-04 | 5 | 169 | 2 | PF00232 | |
| Domain | FerIin_dom | 8.00e-04 | 5 | 169 | 2 | IPR012968 | |
| Domain | FerI | 8.00e-04 | 5 | 169 | 2 | PF08151 | |
| Domain | FerB | 8.00e-04 | 5 | 169 | 2 | PF08150 | |
| Domain | Myosin_S1_N | 8.00e-04 | 5 | 169 | 2 | IPR008989 | |
| Domain | GLYCOSYL_HYDROL_F1_2 | 8.00e-04 | 5 | 169 | 2 | PS00653 | |
| Domain | Glyco_hydro_1 | 8.00e-04 | 5 | 169 | 2 | IPR001360 | |
| Domain | RCC1_1 | 8.59e-04 | 21 | 169 | 3 | PS00625 | |
| Domain | RCC1_2 | 8.59e-04 | 21 | 169 | 3 | PS00626 | |
| Domain | RCC1_3 | 8.59e-04 | 21 | 169 | 3 | PS50012 | |
| Domain | - | 9.88e-04 | 22 | 169 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 9.88e-04 | 22 | 169 | 3 | IPR000408 | |
| Domain | RCC1/BLIP-II | 1.13e-03 | 23 | 169 | 3 | IPR009091 | |
| Domain | Dilute_dom | 1.19e-03 | 6 | 169 | 2 | IPR002710 | |
| Domain | Glyco_hydro_31_AS | 1.19e-03 | 6 | 169 | 2 | IPR030458 | |
| Domain | EFhand_Ca_insen | 1.19e-03 | 6 | 169 | 2 | PF08726 | |
| Domain | DIL | 1.19e-03 | 6 | 169 | 2 | PF01843 | |
| Domain | EF-hand_Ca_insen | 1.19e-03 | 6 | 169 | 2 | IPR014837 | |
| Domain | DILUTE | 1.19e-03 | 6 | 169 | 2 | PS51126 | |
| Domain | DIL | 1.19e-03 | 6 | 169 | 2 | SM01132 | |
| Domain | C2 | 1.24e-03 | 131 | 169 | 6 | PF00168 | |
| Domain | F5_F8_type_C | 1.28e-03 | 24 | 169 | 3 | PF00754 | |
| Domain | FA58C | 1.28e-03 | 24 | 169 | 3 | IPR000421 | |
| Domain | Glycoside_hydrolase_SF | 1.34e-03 | 53 | 169 | 4 | IPR017853 | |
| Domain | C2 | 1.55e-03 | 137 | 169 | 6 | SM00239 | |
| Domain | Galactose-bd-like | 1.64e-03 | 94 | 169 | 5 | IPR008979 | |
| Domain | Glyco_hydro_31 | 1.66e-03 | 7 | 169 | 2 | IPR000322 | |
| Domain | Elp3 | 1.66e-03 | 7 | 169 | 2 | SM00729 | |
| Domain | Glyco_hydro_31 | 1.66e-03 | 7 | 169 | 2 | PF01055 | |
| Domain | Elp3/MiaB/NifB | 1.66e-03 | 7 | 169 | 2 | IPR006638 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.66e-03 | 7 | 169 | 2 | PS00129 | |
| Domain | HECT | 1.81e-03 | 27 | 169 | 3 | PF00632 | |
| Domain | HECTc | 1.81e-03 | 27 | 169 | 3 | SM00119 | |
| Domain | HECT_dom | 1.81e-03 | 27 | 169 | 3 | IPR000569 | |
| Domain | HECT | 1.81e-03 | 27 | 169 | 3 | PS50237 | |
| Domain | C2 | 1.87e-03 | 142 | 169 | 6 | PS50004 | |
| Domain | Villin/Gelsolin | 2.20e-03 | 8 | 169 | 2 | IPR007122 | |
| Domain | Trefoil | 2.20e-03 | 8 | 169 | 2 | PF00088 | |
| Domain | GEL | 2.20e-03 | 8 | 169 | 2 | SM00262 | |
| Domain | - | 2.30e-03 | 148 | 169 | 6 | 2.60.40.150 | |
| Domain | rSAM | 2.81e-03 | 9 | 169 | 2 | IPR007197 | |
| Domain | P_TREFOIL_2 | 2.81e-03 | 9 | 169 | 2 | PS51448 | |
| Domain | Radical_SAM | 2.81e-03 | 9 | 169 | 2 | PF04055 | |
| Domain | PD | 2.81e-03 | 9 | 169 | 2 | SM00018 | |
| Domain | C2_dom | 3.82e-03 | 164 | 169 | 6 | IPR000008 | |
| Domain | - | 4.24e-03 | 11 | 169 | 2 | 4.10.110.10 | |
| Domain | Elongated_TPR_rpt_dom | 4.24e-03 | 11 | 169 | 2 | IPR023114 | |
| Domain | P-loop_NTPase | MYH1 MYH4 ABCC4 MYH8 MYH13 MYO5B MYO7B MYO18A DAPK1 SLFN5 MYO5C DNAH6 RAC1 RAC2 RAC3 DNAH11 | 4.42e-03 | 848 | 169 | 16 | IPR027417 |
| Domain | P_trefoil_dom | 5.06e-03 | 12 | 169 | 2 | IPR000519 | |
| Domain | - | 5.24e-03 | 39 | 169 | 3 | 2.120.10.30 | |
| Domain | VWFA | 6.54e-03 | 82 | 169 | 4 | PS50234 | |
| Domain | Gelsolin | 6.90e-03 | 14 | 169 | 2 | PF00626 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.90e-03 | 14 | 169 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.90e-03 | 14 | 169 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.90e-03 | 14 | 169 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.90e-03 | 14 | 169 | 2 | PF08393 | |
| Domain | Gelsolin-like_dom | 6.90e-03 | 14 | 169 | 2 | IPR007123 | |
| Domain | ATPase_dyneun-rel_AAA | 6.90e-03 | 14 | 169 | 2 | IPR011704 | |
| Domain | MORN | 6.90e-03 | 14 | 169 | 2 | SM00698 | |
| Domain | MT | 6.90e-03 | 14 | 169 | 2 | PF12777 | |
| Domain | AAA_8 | 6.90e-03 | 14 | 169 | 2 | PF12780 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.71e-07 | 70 | 124 | 8 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.12e-05 | 132 | 124 | 8 | M11355 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY | 2.27e-05 | 7 | 124 | 3 | M47538 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 7.62e-05 | 10 | 124 | 3 | M47727 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 9.92e-05 | 28 | 124 | 4 | M47655 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 1.31e-04 | 30 | 124 | 4 | M76 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 1.31e-04 | 30 | 124 | 4 | M47718 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 1.38e-04 | 12 | 124 | 3 | M39408 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 1.99e-04 | 96 | 124 | 6 | M16121 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 2.25e-04 | 14 | 124 | 3 | M13143 | |
| Pathway | WP_FOCAL_ADHESION | 2.45e-04 | 187 | 124 | 8 | MM15913 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.77e-04 | 102 | 124 | 6 | MM15830 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.77e-04 | 102 | 124 | 6 | M39577 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.34e-04 | 38 | 124 | 4 | MM14969 | |
| Pubmed | DOC2A MYH1 MYH4 MYH8 IRS4 MYH13 MYO5B PMPCB BCLAF1 RPS6 SPTA1 SPTAN1 MYO18A PSMD2 PFKM NEB TERF2 UTP18 CLCN5 P4HB AVIL ENTPD2 CAPRIN2 PPP1R9B DNAH6 PRRC2B RAC1 RAC3 DNMT3B | 1.95e-10 | 1442 | 175 | 29 | 35575683 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 9.22e-09 | 6 | 175 | 4 | 10077619 | |
| Pubmed | 2.14e-08 | 7 | 175 | 4 | 35210422 | ||
| Pubmed | The small GTPase Rac1 regulates auditory hair cell morphogenesis. | 9.52e-08 | 23 | 175 | 5 | 20016102 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 16081809 | ||
| Pubmed | Signaling and cytoskeletal requirements in erythroblast enucleation. | 1.25e-07 | 3 | 175 | 3 | 22461493 | |
| Pubmed | rac, a novel ras-related family of proteins that are botulinum toxin substrates. | 1.25e-07 | 3 | 175 | 3 | 2674130 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 22123845 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 34943902 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO5B PMPCB BCLAF1 RPS6 ANXA3 SPTAN1 CAPN1 ARPC1A MYO18A SLU7 BUD13 PSMD2 UNC45A GSN LACTB IARS2 UTP18 P4HB CLK3 CPNE3 PPP1R9B TNKS1BP1 | 4.06e-07 | 1257 | 175 | 22 | 36526897 |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 1985022 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 10388558 | ||
| Pubmed | GABRB3 MYO5B BCLAF1 RPS6 SPTA1 SPTAN1 ARPC1A MYO18A PHYHIP DAPK1 PSMD2 PFKM GSN LACTB NEGR1 P4HB PRKCB PPP1R9B TNKS1BP1 DNAH6 PRRC2B RAC1 DNAH11 | 9.41e-07 | 1431 | 175 | 23 | 37142655 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH4 MYH8 IRS4 MYH13 ANXA3 SPTAN1 MYO18A UNC45A GSN TUBB1 P4HB TNKS1BP1 ADAM17 RAC2 | 1.11e-06 | 647 | 175 | 15 | 26618866 |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.24e-06 | 5 | 175 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.24e-06 | 5 | 175 | 3 | 12919077 | |
| Pubmed | 1.24e-06 | 5 | 175 | 3 | 6196357 | ||
| Pubmed | 1.24e-06 | 5 | 175 | 3 | 8798684 | ||
| Pubmed | PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase. | 1.24e-06 | 5 | 175 | 3 | 22043008 | |
| Pubmed | COL5A1 IRS4 TCF20 USP11 RPS6 ANXA6 SPTAN1 CAPN1 PSMD2 IARS2 UTP18 P4HB TNKS1BP1 HERC2 PRRC2B | 1.24e-06 | 653 | 175 | 15 | 22586326 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MGAM ANXA3 ANXA4 ANXA6 CAPN1 MXRA8 DYSF CTSA LAP3 ITIH4 GSN MYO5C TUBB1 ENTPD2 CPNE3 PAM RAC1 RAC2 RAC3 | 2.15e-06 | 1070 | 175 | 19 | 23533145 |
| Pubmed | 2.48e-06 | 6 | 175 | 3 | 1728586 | ||
| Pubmed | Analysis of erythrocyte and platelet membrane proteins in various forms of beta-thalassemia. | 2.48e-06 | 6 | 175 | 3 | 15310273 | |
| Pubmed | 2.48e-06 | 6 | 175 | 3 | 2138016 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.48e-06 | 6 | 175 | 3 | 10588881 | |
| Pubmed | IRS4 ANXA6 PSMD2 UNC45A PFKM GSN UTP18 GYS1 CPNE3 PPP1R9B ZNF749 KLB | 3.41e-06 | 451 | 175 | 12 | 36168627 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH13 MYO5B ANXA3 ANXA4 ANXA6 CAPN1 ANXA13 ARPC1A MXRA8 FTCD NEB DYSF CTSA LAP3 ITIH4 GSN UPK1B CPNE3 | 4.18e-06 | 1016 | 175 | 18 | 19056867 |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 4.22e-06 | 22 | 175 | 4 | 16526095 | |
| Pubmed | 4.32e-06 | 7 | 175 | 3 | 15226301 | ||
| Pubmed | 4.32e-06 | 7 | 175 | 3 | 16819597 | ||
| Pubmed | 4.32e-06 | 7 | 175 | 3 | 21752934 | ||
| Pubmed | 6.88e-06 | 8 | 175 | 3 | 15964829 | ||
| Pubmed | 6.88e-06 | 8 | 175 | 3 | 3864153 | ||
| Pubmed | Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task. | 6.88e-06 | 8 | 175 | 3 | 24598074 | |
| Pubmed | 6.88e-06 | 8 | 175 | 3 | 27048830 | ||
| Pubmed | 1.46e-05 | 10 | 175 | 3 | 19506036 | ||
| Pubmed | Regulation of lymphatic-blood vessel separation by endothelial Rac1. | 1.46e-05 | 10 | 175 | 3 | 19906871 | |
| Pubmed | 1.54e-05 | 285 | 175 | 9 | 21423176 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.01e-05 | 11 | 175 | 3 | 9655502 | |
| Pubmed | 2.01e-05 | 11 | 175 | 3 | 8136524 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 2.01e-05 | 11 | 175 | 3 | 38303699 | |
| Pubmed | 2.01e-05 | 11 | 175 | 3 | 18786395 | ||
| Pubmed | 2.26e-05 | 33 | 175 | 4 | 36964131 | ||
| Pubmed | Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases. | 2.52e-05 | 2 | 175 | 2 | 15948206 | |
| Pubmed | Rac-deficient cerebellar granule neurons die before they migrate to the internal granule layer. | 2.52e-05 | 2 | 175 | 2 | 36050459 | |
| Pubmed | Rac1 and Rac3 have opposite functions in Schwann cells during developmental myelination. | 2.52e-05 | 2 | 175 | 2 | 33812927 | |
| Pubmed | Identification of a Protein Network Driving Neuritogenesis of MGE-Derived GABAergic Interneurons. | 2.52e-05 | 2 | 175 | 2 | 28066185 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 15504745 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9739041 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 24133251 | ||
| Pubmed | Doc2: a novel brain protein having two repeated C2-like domains. | 2.52e-05 | 2 | 175 | 2 | 7826360 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 15528331 | ||
| Pubmed | Dispensable role of Rac1 and Rac3 after cochlear hair cell specification. | 2.52e-05 | 2 | 175 | 2 | 37204479 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 8163551 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 19955208 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11124526 | ||
| Pubmed | Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. | 2.52e-05 | 2 | 175 | 2 | 14564009 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31369617 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16515538 | ||
| Pubmed | Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice. | 2.52e-05 | 2 | 175 | 2 | 21511011 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.52e-05 | 2 | 175 | 2 | 9382868 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 12027902 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21976675 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11150240 | ||
| Pubmed | Crystal structure of Rac1 bound to its effector phospholipase C-beta2. | 2.52e-05 | 2 | 175 | 2 | 17115053 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21940819 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 2975506 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 12391220 | ||
| Pubmed | Cutting edge: Rac GTPases sensitize activated T cells to die via Fas. | 2.52e-05 | 2 | 175 | 2 | 17982024 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17996650 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 26496249 | ||
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 2.52e-05 | 2 | 175 | 2 | 25830635 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 8993318 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21949760 | ||
| Pubmed | Rac1 and Rac2 control distinct events during antigen-stimulated mast cell exocytosis. | 2.52e-05 | 2 | 175 | 2 | 24399839 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 26582364 | ||
| Pubmed | Annexin A4 and A6 induce membrane curvature and constriction during cell membrane repair. | 2.52e-05 | 2 | 175 | 2 | 29158488 | |
| Pubmed | Rac2 is required for the formation of neutrophil extracellular traps. | 2.52e-05 | 2 | 175 | 2 | 21712395 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 20807704 | ||
| Pubmed | Human monocytes use Rac1, not Rac2, in the NADPH oxidase complex. | 2.52e-05 | 2 | 175 | 2 | 12912997 | |
| Pubmed | Rac-Dependent Signaling from Keratinocytes Promotes Differentiation of Intradermal White Adipocytes. | 2.52e-05 | 2 | 175 | 2 | 31351086 | |
| Pubmed | Rac1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome. | 2.52e-05 | 2 | 175 | 2 | 31221776 | |
| Pubmed | Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. | 2.52e-05 | 2 | 175 | 2 | 18579797 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 35421597 | ||
| Pubmed | Specific roles of Rac1 and Rac2 in motile functions of HT1080 fibrosarcoma cells. | 2.52e-05 | 2 | 175 | 2 | 19555660 | |
| Pubmed | Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. | 2.52e-05 | 2 | 175 | 2 | 16025125 | |
| Pubmed | Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. | 2.52e-05 | 2 | 175 | 2 | 16027728 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 20883775 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9299243 | ||
| Pubmed | DOC2 isoforms play dual roles in insulin secretion and insulin-stimulated glucose uptake. | 2.52e-05 | 2 | 175 | 2 | 25005332 | |
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 2.52e-05 | 2 | 175 | 2 | 8518795 | |
| Pubmed | Rac1 and Rac2 in osteoclastogenesis: a cell immortalization model. | 2.52e-05 | 2 | 175 | 2 | 19649754 | |
| Pubmed | Transforming mutations of RAC guanosine triphosphatases in human cancers. | 2.52e-05 | 2 | 175 | 2 | 23382236 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16280046 | ||
| Pubmed | Molecular cloning of an isoform of Doc2 having two C2-like domains. | 2.52e-05 | 2 | 175 | 2 | 8554557 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 36599922 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31594980 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21469092 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 20065081 | ||
| Pubmed | Rac1 and Rac3 have opposing functions in cell adhesion and differentiation of neuronal cells. | 2.52e-05 | 2 | 175 | 2 | 17244648 | |
| Interaction | GRIN2B interactions | SPTA1 SPTAN1 CAPN1 DAPK1 KCNB2 OTUD7A PRKCB PPP1R9B FYN RAC1 | 1.96e-06 | 170 | 171 | 10 | int:GRIN2B |
| Interaction | RSPH6A interactions | 9.46e-06 | 34 | 171 | 5 | int:RSPH6A | |
| Interaction | MYO19 interactions | MYO5B SPTAN1 MYO18A UNC45A GSN MYO5C EXD2 PPP1R9B PALLD RAC1 RAC2 | 1.07e-05 | 252 | 171 | 11 | int:MYO19 |
| Interaction | SPTBN1 interactions | USP11 SPTAN1 CAPN1 MYO18A DAPK1 FTCD MYO5C OTUD7A PPP1R9B TNKS1BP1 HERC2 RAC1 RAC2 RAC3 | 1.50e-05 | 421 | 171 | 14 | int:SPTBN1 |
| Interaction | ACTN2 interactions | 1.59e-05 | 171 | 171 | 9 | int:ACTN2 | |
| Interaction | RAP1GDS1 interactions | 2.77e-05 | 141 | 171 | 8 | int:RAP1GDS1 | |
| Interaction | KRIT1 interactions | 3.45e-05 | 44 | 171 | 5 | int:KRIT1 | |
| Interaction | AMIGO2 interactions | 4.66e-05 | 24 | 171 | 4 | int:AMIGO2 | |
| Interaction | MYO18A interactions | MYO5B USP11 SPTAN1 MYO18A GSN LACTB MYO5C FYN RAC1 RAC2 RAC3 | 5.80e-05 | 303 | 171 | 11 | int:MYO18A |
| Interaction | TMOD1 interactions | 7.12e-05 | 161 | 171 | 8 | int:TMOD1 | |
| Interaction | DHCR7 interactions | 7.37e-05 | 258 | 171 | 10 | int:DHCR7 | |
| Interaction | MYH9 interactions | MYO5B PMPCB USP11 SPTAN1 MYO18A PSMD2 UNC45A TERF2 CD163 GSN MYO5C IARS2 PPP1R9B TNKS1BP1 FYN DNAH6 PALLD RAC1 | 7.68e-05 | 754 | 171 | 18 | int:MYH9 |
| Interaction | KCNQ2 interactions | 8.04e-05 | 84 | 171 | 6 | int:KCNQ2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 2.68e-04 | 325 | 175 | 7 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.90e-04 | 346 | 175 | 7 | chr17p13 | |
| GeneFamily | Annexins|Endogenous ligands | 1.10e-06 | 13 | 116 | 4 | 404 | |
| GeneFamily | Myosin heavy chains | 2.08e-06 | 15 | 116 | 4 | 1098 | |
| GeneFamily | Myosins, class V | 1.22e-04 | 3 | 116 | 2 | 1100 | |
| GeneFamily | Rho family GTPases | 2.71e-04 | 20 | 116 | 3 | 390 | |
| GeneFamily | Ferlin family | 6.02e-04 | 6 | 116 | 2 | 828 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.39e-04 | 7 | 116 | 2 | 1113 | |
| GeneFamily | Gelsolin/villins | 1.11e-03 | 8 | 116 | 2 | 950 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 1.78e-03 | 10 | 116 | 2 | 822 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.29e-09 | 197 | 175 | 10 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-08 | 182 | 175 | 9 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.29e-08 | 185 | 175 | 9 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.03e-07 | 200 | 175 | 9 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.03e-07 | 200 | 175 | 9 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-07 | 200 | 175 | 9 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 1.03e-07 | 200 | 175 | 9 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-07 | 200 | 175 | 9 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.03e-07 | 200 | 175 | 9 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 1.22e-07 | 204 | 175 | 9 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 151 | 175 | 8 | a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 154 | 175 | 8 | 8c65d4ea787a75f20448b11beea571d7ec684721 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 154 | 175 | 8 | 60e7c03d91ea87eb6226a744633cbe6efa9a9928 | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-07 | 170 | 175 | 8 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.19e-07 | 177 | 175 | 8 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.42e-07 | 178 | 175 | 8 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 5.42e-07 | 178 | 175 | 8 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | Monocytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.15e-07 | 181 | 175 | 8 | d8b98c3d9bef026a0a35948219027f27718ffbee | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-07 | 181 | 175 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.41e-07 | 182 | 175 | 8 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.41e-07 | 182 | 175 | 8 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.41e-07 | 182 | 175 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-07 | 183 | 175 | 8 | 2df1611c8acccb2a6f233d3d68bd9df2381a7278 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-07 | 184 | 175 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-07 | 184 | 175 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-07 | 184 | 175 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.26e-07 | 185 | 175 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.26e-07 | 185 | 175 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.87e-07 | 187 | 175 | 8 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.87e-07 | 187 | 175 | 8 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.19e-07 | 188 | 175 | 8 | adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 8.19e-07 | 188 | 175 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.53e-07 | 189 | 175 | 8 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.53e-07 | 189 | 175 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-07 | 189 | 175 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.53e-07 | 189 | 175 | 8 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Monocytes-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.53e-07 | 189 | 175 | 8 | 22d08c7dde697f385100f72e009eeac8d19d329d | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 8.53e-07 | 189 | 175 | 8 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.53e-07 | 189 | 175 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.53e-07 | 189 | 175 | 8 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.87e-07 | 190 | 175 | 8 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 8.87e-07 | 190 | 175 | 8 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 8.87e-07 | 190 | 175 | 8 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.87e-07 | 190 | 175 | 8 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.87e-07 | 190 | 175 | 8 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.23e-07 | 191 | 175 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.23e-07 | 191 | 175 | 8 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.23e-07 | 191 | 175 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.23e-07 | 191 | 175 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.60e-07 | 192 | 175 | 8 | aa65557b35d3eba9f24b970849255d05174d1c05 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.60e-07 | 192 | 175 | 8 | d44f46352bac414b45cc749f7cbdc3a159bd7ae8 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.98e-07 | 193 | 175 | 8 | 5f0eba7b1440beb891d94a288f7f18a4e13c3a88 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.98e-07 | 193 | 175 | 8 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.04e-06 | 194 | 175 | 8 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.04e-06 | 194 | 175 | 8 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-06 | 194 | 175 | 8 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 1.04e-06 | 194 | 175 | 8 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 194 | 175 | 8 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-06 | 194 | 175 | 8 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.04e-06 | 194 | 175 | 8 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 195 | 175 | 8 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 1.08e-06 | 195 | 175 | 8 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 195 | 175 | 8 | cd6cfe3ef150a4a4575e04fc8a8213cdceefa1c4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 195 | 175 | 8 | 2d19148df56e99f66b596af2d7f9d0f10f9a9087 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 195 | 175 | 8 | 43f0c257e4bb5c627afbdfc695c1199c672842d3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 195 | 175 | 8 | b78db0d929be6b04055805ea5ffecc56c47ba956 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.08e-06 | 195 | 175 | 8 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 195 | 175 | 8 | e22ca35bea06aa95ff2cc771632969f5e7229ffc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.12e-06 | 196 | 175 | 8 | 7c8aa5853d7096628e35af665097c0299c329753 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.12e-06 | 196 | 175 | 8 | bcd274db4955ea76ca26267a272c7d1929db24f4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 196 | 175 | 8 | 5dbe38aef369811d981c0109829563ac66dcc684 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-06 | 196 | 175 | 8 | f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-06 | 196 | 175 | 8 | 80b9139d91dda4de69830d2d443859e047ab5503 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM1|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.12e-06 | 196 | 175 | 8 | ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa | |
| ToppCell | COVID-19_Severe-PLT_0|COVID-19_Severe / Disease Group and Platelet Clusters | 1.16e-06 | 197 | 175 | 8 | dbdeefa72d10f2c5f75ad5aac6f31a892d4e94a9 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 1.16e-06 | 197 | 175 | 8 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-06 | 197 | 175 | 8 | 0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-06 | 197 | 175 | 8 | a6aa5991d566c28440f7e24a30933e69669064f2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-06 | 198 | 175 | 8 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | NS-control-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-06 | 198 | 175 | 8 | 846852943a8ff60f746fd49498240e25ca1c1b09 | |
| ToppCell | Severe_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 1.21e-06 | 198 | 175 | 8 | 09fd456077bb3a657ad3b10c6cfe799b7266456a | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 1.21e-06 | 198 | 175 | 8 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-06 | 198 | 175 | 8 | 687f69c16343227854c882b4a0f3930ce534a3d2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-06 | 198 | 175 | 8 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-06 | 198 | 175 | 8 | 0b928a829844f49f4d47e88908af192cb919011f | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-06 | 198 | 175 | 8 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | distal-Epithelial-Ciliated-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-06 | 198 | 175 | 8 | d30d6c6a0a78b7571318b5b2a0186df96dd0f5a9 | |
| ToppCell | distal-Hematologic-Classical_Monocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-06 | 199 | 175 | 8 | bd8519da7a90f0b90626b86c6be0d62248a0a24a | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-06 | 199 | 175 | 8 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-06 | 199 | 175 | 8 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 200 | 175 | 8 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-06 | 200 | 175 | 8 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.30e-06 | 200 | 175 | 8 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-06 | 200 | 175 | 8 | 23bc13983f6bdf95e63109b8bc14c4921ca85c3a | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 1.30e-06 | 200 | 175 | 8 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.30e-06 | 200 | 175 | 8 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-06 | 200 | 175 | 8 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.30e-06 | 200 | 175 | 8 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| Computational | Metal / Ca ion binding. | 1.29e-05 | 133 | 116 | 9 | MODULE_324 | |
| Drug | trifluoperazine | MYH1 MGAM MYH4 MYH8 MYH13 MYO5B ANXA3 ANXA4 SPTA1 ANXA6 SPTAN1 ANXA13 MYO18A PFKM MYO5C LY6G6F ACTR6 GYS1 PRKCB | 5.89e-12 | 324 | 172 | 19 | CID000005566 |
| Drug | NSC339663 | MYH1 MYH4 MYH8 MYH13 MYO5B MYO18A GSN MYO5C TUBB1 ACTR6 AVIL PPP1R9B TUBA4B RAC1 RAC2 RAC3 | 8.23e-11 | 250 | 172 | 16 | CID000003892 |
| Drug | AC1L1IZ2 | MYH1 MGAM MYH4 MYH8 MYH13 MYO5B ARPC1A MYO18A PSMD2 PFKM GSN MYO5C TUBB1 ACTR6 ENTPD2 TUBA4B | 1.45e-09 | 304 | 172 | 16 | CID000004795 |
| Drug | MgCl2 | MYH1 MGAM MYH4 MYH8 MYH13 MYO5B SPTA1 SPTAN1 MYO18A PFKM GSN MYO5C TUBB1 IARS2 ACTR6 ENTPD2 TUBA4B | 1.74e-09 | 354 | 172 | 17 | CID000024584 |
| Drug | formycin triphosphate | 4.35e-09 | 51 | 172 | 8 | CID000122274 | |
| Drug | purealin | 1.25e-08 | 58 | 172 | 8 | CID006419303 | |
| Drug | NSC107658 | MYH1 MYH4 MYH8 MYH13 MYO5B SPTA1 SPTAN1 MYO18A GSN MYO5C TUBB1 BNC1 ACTR6 PRKCB TUBA4B | 1.25e-08 | 306 | 172 | 15 | CID000002919 |
| Drug | blebbistatin | 2.48e-07 | 116 | 172 | 9 | CID003476986 | |
| Drug | B0683 | 3.05e-06 | 117 | 172 | 8 | CID006398969 | |
| Drug | magnesium | MGAM ITGA11 MYO5B ARPC1A PFKM IDI1 TERF2 LAP3 GSN MYO5C TUBB1 GBA3 IARS2 ACTR6 GYS1 SERGEF ENTPD2 PRKCB ACP4 ADAM17 TUBA4B FYN RAC1 RAC2 RAC3 DNAH11 | 7.38e-06 | 1325 | 172 | 26 | CID000000888 |
| Drug | B258 | 8.33e-06 | 6 | 172 | 3 | CID000593690 | |
| Drug | AC1NRBPQ | 9.85e-06 | 137 | 172 | 8 | CID005288569 | |
| Drug | S-(-)-Etomoxir | 1.10e-05 | 100 | 172 | 7 | CID000060765 | |
| Drug | candesartan cilexetil | 1.49e-05 | 145 | 172 | 8 | CID000002540 | |
| Drug | fast white | 1.57e-05 | 42 | 172 | 5 | CID000024008 | |
| Drug | AC1N9ZZC | 1.82e-05 | 149 | 172 | 8 | CID004369374 | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; HL60; HT_HG-U133A | 2.14e-05 | 199 | 172 | 9 | 2167_DN | |
| Drug | eye gene | MYH1 MYH4 MYH8 MYH13 MYO5B MYO18A MYO5C IARS2 CACNA2D4 ACTR6 GYS1 PRKCB | 2.54e-05 | 369 | 172 | 12 | CID000004782 |
| Drug | phorbol 12-myristate | 3.10e-05 | 261 | 172 | 10 | CID000107854 | |
| Drug | SM-2 | 5.19e-05 | 87 | 172 | 6 | CID000486033 | |
| Drug | dibenzocarbazole | 5.67e-05 | 2 | 172 | 2 | CID000155584 | |
| Drug | glycerol | PLA2G7 LIAS MGAM ANXA3 SPTA1 SPTAN1 PFKM NRP2 TUBB1 GBA3 P4HB GYS1 LRP5 PAM PRKCB ACP4 TUBA4B RAC3 | 5.93e-05 | 829 | 172 | 18 | CID000000753 |
| Disease | kidney disease (implicated_via_orthology) | 3.70e-09 | 41 | 171 | 7 | DOID:557 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.72e-09 | 12 | 171 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | COL5A1 TCF20 ANXA3 ANXA4 SPTAN1 FTCD DYSF GASK1B CD163 GSN PRODH2 PTPRC FCN1 SLC20A1 PRKCB ADAM17 FGR FYN RAC2 | 1.36e-07 | 774 | 171 | 19 | C0023893 |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.89e-07 | 71 | 171 | 7 | DOID:0050700 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 1.91e-07 | 3 | 171 | 3 | DOID:0080235 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.23e-07 | 10 | 171 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 5.20e-07 | 12 | 171 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.47e-07 | 13 | 171 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.41e-06 | 15 | 171 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 2.31e-05 | 29 | 171 | 4 | EFO_0008009 | |
| Disease | osteoporosis-pseudoglioma syndrome (implicated_via_orthology) | 3.34e-05 | 2 | 171 | 2 | DOID:0060849 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | PCSK2 ABCC4 IRS4 MYOT ZBTB8B SETD4 KCNB2 HPS3 FCN1 PRKCB KDM2A JPH3 ZNF572 PDZRN4 | 6.42e-05 | 702 | 171 | 14 | C0009402 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 6.64e-05 | 14 | 171 | 3 | DOID:898 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.04e-04 | 80 | 171 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.74e-04 | 48 | 171 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | kallikrein-7 measurement | 3.30e-04 | 5 | 171 | 2 | EFO_0008195 | |
| Disease | airway responsiveness measurement | 3.54e-04 | 24 | 171 | 3 | EFO_0006897 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 4.93e-04 | 6 | 171 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | tendinitis (biomarker_via_orthology) | 4.93e-04 | 6 | 171 | 2 | DOID:971 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | FNDC3B MYH1 RPS6 SPTAN1 TP53I3 CHEK1 DYSF GSN JAG2 LLGL2 PTPRC UPK1B TLL1 HERC2 RAC2 DNMT3B | 5.40e-04 | 1074 | 171 | 16 | C0006142 |
| Disease | polycystic liver disease (implicated_via_orthology) | 6.88e-04 | 7 | 171 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 6.88e-04 | 7 | 171 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 6.88e-04 | 7 | 171 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | osteonecrosis (biomarker_via_orthology) | 6.88e-04 | 7 | 171 | 2 | DOID:10159 (biomarker_via_orthology) | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 7.63e-04 | 31 | 171 | 3 | C0023493 | |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 9.14e-04 | 8 | 171 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | FNDC3B FAT3 PCDHA11 PCDHA10 PFKM DYSF TERF2 CLDN23 CCDC197 CDKAL1 GSN LACTB CPXM1 FGR FER1L5 PALLD DNMT3B KLB | 1.25e-03 | 1392 | 171 | 18 | EFO_0005763 |
| Disease | longevity | 1.39e-03 | 284 | 171 | 7 | EFO_0004300 | |
| Disease | late-onset Alzheimers disease | 1.63e-03 | 292 | 171 | 7 | EFO_1001870 | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 1.77e-03 | 11 | 171 | 2 | EFO_0009923 | |
| Disease | ximenoylcarnitine (C26:1) measurement | 2.50e-03 | 13 | 171 | 2 | EFO_0800543 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 2.50e-03 | 13 | 171 | 2 | EFO_0800413 | |
| Disease | Primary Ciliary Dyskinesia | 2.57e-03 | 47 | 171 | 3 | C4551720 | |
| Disease | orotic acid measurement | 2.90e-03 | 14 | 171 | 2 | EFO_0010516 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.90e-03 | 14 | 171 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | triacylglycerol 46:2 measurement | 2.90e-03 | 14 | 171 | 2 | EFO_0010402 | |
| Disease | early cardiac repolarization measurement | 2.90e-03 | 14 | 171 | 2 | EFO_0004885 | |
| Disease | Weight Gain | 2.98e-03 | 102 | 171 | 4 | C0043094 | |
| Disease | triacylglycerol 50:5 measurement | 3.80e-03 | 16 | 171 | 2 | EFO_0010412 | |
| Disease | diacylglycerol 44:7 measurement | 3.80e-03 | 16 | 171 | 2 | EFO_0020069 | |
| Disease | facial morphology | 4.02e-03 | 55 | 171 | 3 | EFO_0004743 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.16e-03 | 112 | 171 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Inborn Errors of Metabolism | 4.29e-03 | 17 | 171 | 2 | C0025521 | |
| Disease | muscular dystrophy (is_implicated_in) | 4.29e-03 | 17 | 171 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Drug habituation | 4.57e-03 | 115 | 171 | 4 | C0013170 | |
| Disease | Drug abuse | 4.57e-03 | 115 | 171 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.57e-03 | 115 | 171 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.57e-03 | 115 | 171 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.57e-03 | 115 | 171 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.57e-03 | 115 | 171 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.57e-03 | 115 | 171 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.57e-03 | 115 | 171 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.57e-03 | 115 | 171 | 4 | C0029231 | |
| Disease | Substance abuse problem | 4.71e-03 | 116 | 171 | 4 | C0740858 | |
| Disease | neuroblastoma | 4.71e-03 | 116 | 171 | 4 | EFO_0000621 | |
| Disease | creatine kinase measurement | 4.90e-03 | 59 | 171 | 3 | EFO_0004534 | |
| Disease | sleep duration | 5.33e-03 | 362 | 171 | 7 | EFO_0005271 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 5.35e-03 | 19 | 171 | 2 | EFO_0002609, GO_0031427 | |
| Disease | cerebral infarction (is_marker_for) | 5.35e-03 | 19 | 171 | 2 | DOID:3526 (is_marker_for) | |
| Disease | glomerulonephritis (is_marker_for) | 5.35e-03 | 19 | 171 | 2 | DOID:2921 (is_marker_for) | |
| Disease | Post-Traumatic Osteoporosis | 5.38e-03 | 61 | 171 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 5.38e-03 | 61 | 171 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 5.38e-03 | 61 | 171 | 3 | C0001787 | |
| Disease | Schizophrenia | GABRB3 MYO5B CHEK1 BTBD9 CD163 GSN JAG2 PRODH2 PPP1R9B CSMD1 FYN DNMT3B | 5.53e-03 | 883 | 171 | 12 | C0036341 |
| Disease | metabolite measurement | 5.56e-03 | 560 | 171 | 9 | EFO_0004725 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.69e-03 | 195 | 171 | 5 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITYAWEGGKLISEND | 356 | Q9GZN1 | |
| DVQDKGGSNAVYWAA | 406 | P53355 | |
| KDSERDELYAQWGKG | 486 | Q9BRD0 | |
| DELYAQWGKGLAQSR | 491 | Q9BRD0 | |
| WSAGKTYEQLKEELG | 716 | O75366 | |
| DEDSELVGVYAWRKG | 276 | A0A096LP49 | |
| SKFENDNWGLDGYVS | 3426 | Q96PZ7 | |
| EIYKGSCNWEESGLL | 6 | Q8N2A0 | |
| DEEYADNFGKATWGE | 321 | Q96L12 | |
| VEDWDLVQTLGEGAY | 6 | O14757 | |
| EYQDGKEFGIGDLVW | 216 | Q9UBC3 | |
| GYVLQDASGKVLDHW | 141 | Q01954 | |
| ILYKAGENRWGTDED | 181 | P12429 | |
| YKGGLVWDENSSDGR | 556 | P49761 | |
| LWSVGLVIQDYDADK | 326 | O75131 | |
| GDLYDGAWCAEEQDA | 156 | Q96SM3 | |
| NKEVRVWDAYTGLEG | 1371 | Q96DT5 | |
| YRWGGKTDIDLAVDE | 256 | O95490 | |
| IDKDGNYWVTDVALH | 586 | P19021 | |
| KDLYDAGEGRWGTDE | 176 | P27216 | |
| LYGWGEKQTDTGSQK | 186 | Q6IQ19 | |
| SAYNVKLAWRDGEDI | 116 | Q9BSQ5 | |
| QDLYEAGEKKWGTDE | 176 | P09525 | |
| GYGKIWLDDVSCDGD | 641 | Q9NR16 | |
| AEGNEFWSALLEKAY | 181 | P07384 | |
| IDDWKYLAEEEGTFG | 301 | Q8IWG1 | |
| GDKEGDLQGLWQELY | 16 | Q8NCU1 | |
| KSLAVSQGGELYEEW | 86 | Q5RIA9 | |
| GADRNAYVWSQKDGV | 71 | Q92747 | |
| VQDLYEAGELKWGTD | 181 | P08133 | |
| AAKSGEAWYEGNLGA | 196 | Q9UF12 | |
| GQYEREKAGFSWIEV | 771 | Q14624 | |
| TLDGKVQYLVEWEGA | 576 | Q9Y483 | |
| KVTDQYGDIWTLHDG | 691 | Q6ZMN7 | |
| EYSTGCEIDWNEGKN | 326 | Q9ULW6 | |
| VNLGLWDTAGQEDYD | 51 | P15153 | |
| VNLGLWDTAGQEDYD | 51 | P60763 | |
| NLILDCIGGSYWEKN | 211 | Q53FA7 | |
| VNLGLWDTAGQEDYD | 51 | P63000 | |
| LGNYSLWLEGSKEED | 86 | Q5SQ64 | |
| KLYGSGDQEAWQKGV | 176 | P28838 | |
| VGLWIDAGSRYENEK | 81 | O75439 | |
| AKVRAVDADSGYNAW | 591 | Q9Y5I1 | |
| EADLLQDQEGYRWKG | 546 | Q6P1M3 | |
| YLEDGASKGAWLNRS | 61 | Q7Z3B1 | |
| VDSIQAEEWYFGKIG | 136 | P09769 | |
| GELYWDDGVSKDAVT | 801 | Q2M2H8 | |
| KGGVDAALEYAKTWS | 91 | Q9P107 | |
| SEGEVYSWGEAEDGK | 4056 | O95714 | |
| ETNWGGLLCDKDLNY | 296 | Q9Y219 | |
| YWTADGDLDIGAKNV | 576 | O60303 | |
| LFWDDGQSIDTYGKG | 2646 | O43451 | |
| KEVWSEGLGYADVEN | 136 | P83111 | |
| DLQEGKLYWGDAKTD | 511 | O75197 | |
| KSLAVSQGGELYEEW | 86 | Q8IUF1 | |
| KSLAVSQGGELYEEW | 86 | Q9BRT8 | |
| AQWYLDKGIGELVSE | 376 | Q9NVH0 | |
| QKKAADTAVGWALGY | 426 | Q9Y5L3 | |
| AGTVDYNITGWLDKN | 586 | P13535 | |
| EQENDIFLGWEKGAY | 76 | Q92628 | |
| VGYLQWGKDASEDDR | 336 | A8MYZ0 | |
| EVDDDDAGGEWRLKY | 1361 | Q92614 | |
| DYVQEVTKAGEGLWV | 101 | Q9H2J4 | |
| EGLAKGQIEEAGWSY | 441 | P08237 | |
| DKGQVYAWGLDSDGQ | 101 | Q5GLZ8 | |
| LQVGEGDCKYDWLDI | 201 | O60462 | |
| LALDLQEGKLYWGDA | 126 | A4QPB2 | |
| ANSDGLIASLWKEYG | 71 | Q9BY08 | |
| DDEGVLVGSWDNIYA | 271 | P00488 | |
| GDLADRSTWDEYKGN | 51 | O43766 | |
| TDDIEFYWRGGDKAV | 186 | P28472 | |
| VDGWFKLLSQEEGEY | 271 | P05771 | |
| AGTVDYNIAGWLDKN | 586 | P12882 | |
| GAYDWNGAVLKETSA | 386 | Q9UKX5 | |
| YTAGREADDIVNWLK | 116 | P07237 | |
| GKNWDLTAALSDYEQ | 51 | Q8TE49 | |
| YQGAKFAWESADSGL | 341 | Q32M88 | |
| KDQSAAEIGDKSWLY | 191 | Q13093 | |
| AFYEAGIAAKAVGWD | 1576 | Q9UG01 | |
| AKVRAVDADSGYNAW | 591 | Q9Y5I2 | |
| AHGDLNTGYDVVLWK | 466 | Q5T6X5 | |
| EDAGWYTVSAKNEAG | 1301 | Q8WX93 | |
| GLADSGWFLDNKQYR | 261 | Q6P988 | |
| GGGNVTEKLDLNWYL | 751 | O15439 | |
| WLVKYGDSGEQIAGF | 426 | P10619 | |
| EAAEYQEALEGWTGF | 171 | Q9BZG2 | |
| DWAAYKQGFGSQLGE | 171 | O00602 | |
| QSLFLDKVYWESQGG | 471 | Q6UWH4 | |
| GFWNSYLQAVEDGKS | 611 | Q7L622 | |
| LYGEVNNLTLEWKDG | 1801 | Q9C0G6 | |
| YKAQSDGIWGEHEID | 136 | Q13907 | |
| WGQLGEDSDYDKLSD | 846 | A4D2P6 | |
| LELYENWLLSGKQGD | 241 | Q9Y2K7 | |
| ALSFGQELDYWGIDE | 116 | Q92953 | |
| SLDQDDYLWGLEAGE | 406 | Q14209 | |
| WDYDIGKSNDFIGGV | 341 | Q14183 | |
| WDYDIGKSNDFIGGV | 356 | Q14184 | |
| GGWLSEAIIESFDKY | 131 | Q9H227 | |
| TVKLWADTFGGDLYN | 76 | Q7Z3S7 | |
| GYKITENASDADLWL | 91 | Q5VV42 | |
| NYLLEWDEGKRNSGF | 411 | Q53EP0 | |
| VDSIQAEEWYFGKLG | 141 | P06241 | |
| KWTHDKYQGDGIVED | 886 | Q9NYF8 | |
| KWVADALGREGIYDA | 616 | P51795 | |
| SWDIKYRIVSGDEEG | 76 | Q8TDW7 | |
| KSLAVSQGGELYEEW | 86 | Q5JTY5 | |
| KSLAVSQGGELYEEW | 86 | Q4V339 | |
| KGNFDWEAIFDAGTL | 306 | Q92949 | |
| AWQDAATGSYDKALR | 1751 | P20908 | |
| YFWDLLEGSEKAVVG | 281 | Q6IMN6 | |
| RGAATWGQEKAEYAT | 216 | P0C7T7 | |
| AEAWARGGYAAEKEE | 291 | Q8NEP3 | |
| YGGWKNDTIIDIFND | 206 | Q86Z14 | |
| AAYLWVGTGASEAEK | 601 | P06396 | |
| AKVTGDEWGDNYFLV | 51 | P13807 | |
| ALLNGDTKNYDWDSG | 446 | Q96Q07 | |
| QWGGLTCDHYEEAKI | 456 | Q86VB7 | |
| GDRKGSNGSLEEWYD | 491 | Q8WUM9 | |
| QAEAEGEGWEYASLF | 1061 | O75923 | |
| AYTNSVDVLDGEGWE | 256 | Q96B33 | |
| GIGWYLDEKNLAQVS | 221 | O95954 | |
| SADKGSLEVATQYGW | 506 | Q969Z0 | |
| FLGRGLDKEVSYNWD | 836 | O14654 | |
| SGDGEVYVWDVNSRK | 401 | Q9Y5J1 | |
| SLTDAGEVYVWGSNK | 226 | Q9UGK8 | |
| VAADALGEEWKGYVV | 36 | P62753 | |
| EAAIEWYAKGALETE | 711 | Q68CR1 | |
| EVDDRGLYKEGQNWL | 131 | Q9BY50 | |
| GGVEWLQIKDNDFSY | 121 | Q969F1 | |
| VDKQHVYIGSAGLDW | 226 | Q8N7P1 | |
| SSNWVGKGFAAVYEA | 446 | O43897 | |
| ELNHAVDSKGWEYGV | 906 | A0AVI2 | |
| TDWTVEDGLQKYERG | 591 | Q969F9 | |
| YEGQKLLDSLAETWD | 106 | P85299 | |
| GQDKLLTDDGNKWLY | 386 | Q13200 | |
| KLEWAFSLYDVDGNG | 101 | P35243 | |
| GWQGLKEYDQALADL | 316 | Q08752 | |
| TYGSATQDLIGEKWE | 181 | Q6ZW05 | |
| GTLGDSELEKSVYWD | 301 | O43147 | |
| LKDHGYIENLTFGWD | 321 | Q9NVD3 | |
| WAKGHYTEGAELIEN | 101 | Q9H4B7 | |
| AGTVDYNIAGWLDKN | 586 | Q9Y623 | |
| DLYEAADKWVAAVGK | 306 | Q9H7Z7 | |
| AVKQSDGEYLVSGWS | 91 | Q92561 | |
| YLEGKDQLGGWFQSS | 621 | Q9NSE4 | |
| LITGKEDAANNYAWG | 31 | Q9H853 | |
| SWDNAGFKGYGIQIE | 266 | P78536 | |
| YESDGKSENWGNFIA | 86 | Q7Z3I7 | |
| GHLEEQLYATDAWGK | 76 | Q9BZM4 | |
| VGEWKGQKASYNGLD | 131 | Q8IW36 | |
| GWKLYRDTQDGEAFQ | 176 | O43361 | |
| AEADKLSIWYDVGGI | 326 | Q8NCC5 | |
| AGGKAWDEQERDAYA | 466 | Q8N2H3 | |
| WIGEKENSLKTDDYG | 1991 | Q13813 | |
| WEFGKRDSLGAYASQ | 886 | Q9C0C2 | |
| GTVDYNIAGWLDKNK | 586 | Q9UKX3 | |
| GWAGLHEEVDYSEKL | 371 | Q5JSZ5 | |
| AWEAYDKGSEVHLQA | 331 | O95391 | |
| VEWQVTSEDYGKGLA | 706 | P02549 | |
| GEEDVIYTWKALGQA | 156 | Q9NQ25 | |
| EYKDWSSGSAQGVIA | 1096 | Q9UGU0 | |
| LLEATDNDDIYGAAW | 46 | O75841 | |
| WGEGKQTYGDIEVDL | 1076 | P08575 | |
| KGLDWEGRSSTEKNY | 116 | Q8NCK3 | |
| GEIAEAYADLVKQAW | 356 | P51784 | |
| AQNFRTEDGDWYGKA | 651 | Q08AF3 | |
| TEDGDWYGKAKFITQ | 656 | Q08AF3 | |
| ESEWVKAGVQKYGEG | 496 | Q15554 | |
| ENYIKSWFEGQGLAG | 396 | Q9H3U1 | |
| EWIDDKGVFVAGYES | 31 | Q6P4I2 | |
| VQADWYGEDSGDVLV | 321 | Q8NAP8 | |
| GSQYDAIWENGLAIK | 51 | Q5VZ52 | |
| GVSQRSDGLKYEGEW | 301 | Q8WXH2 | |
| GSGYFDVRDKEDQWI | 101 | Q9BV57 | |
| YWDGEKEVLAVARGA | 166 | Q9BRK3 | |
| KTEDWGYLNEDGELG | 1316 | Q9ULV0 | |
| LNEDGELWFAYEGLK | 1131 | Q9NQX4 | |
| LRGVWSGEYSFEKEE | 1311 | Q6PIF6 | |
| KDAGWYTVSAVNEAG | 416 | Q9UBF9 | |
| EKLEGYWGEAQSLCQ | 721 | Q96SB3 | |
| DNVYKDDLNWLKGIG | 4596 | P20929 | |
| LNVAEAWELGYTGKG | 146 | P16519 |